College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan 430065, P. R. China.
Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences, Wuhan 430074, P. R. China.
Food Funct. 2022 Apr 20;13(8):4757-4769. doi: 10.1039/d1fo03899k.
In this study, polysaccharides were degraded into oligosaccharides. The structural features were analyzed by HPLC, HPLC-MS, FT-IR, and NMR spectroscopy. The results indicated that oligosaccharides (BOs) were composed of mannose and glucose with a molar ratio of 5.2 : 1, and the main backbones of BOs contained (1→4)-linked-α-D-Man, (1→2)-linked-α-D-Man, and (1→2)-linked-α-D-Glc. By using a high-fat diet (HFD)-induced mouse model, we demonstrated that BOs had an improving effect on non-alcoholic fatty liver disease (NAFLD). Using the metabolomics assay, we found that BOs significantly regulated the hepatic metabolism of fatty acids, arachidonic acid, and other related metabolites in HFD-fed mice, accompanied by the reduction of lipid accumulation and fibrosis in liver tissues. In summary, BOs displayed high potential for the treatment of NAFLD as a functional food.
在这项研究中,多糖被降解成低聚糖。通过 HPLC、HPLC-MS、FT-IR 和 NMR 光谱分析其结构特征。结果表明,低聚糖(BOs)由甘露糖和葡萄糖组成,摩尔比为 5.2∶1,BOs 的主要骨架含有(1→4)-连接-α-D-Man、(1→2)-连接-α-D-Man 和(1→2)-连接-α-D-Glc。通过使用高脂肪饮食(HFD)诱导的小鼠模型,我们证明 BOs 对非酒精性脂肪性肝病(NAFLD)具有改善作用。通过代谢组学分析,我们发现 BOs 可显著调节 HFD 喂养小鼠肝脏脂肪酸、花生四烯酸和其他相关代谢物的代谢,同时减少肝组织中的脂质积累和纤维化。总之,BOs 作为一种功能性食品,具有治疗非酒精性脂肪性肝病的巨大潜力。